Where Does Aslan Pharmaceuticals Ltd (ASLN) Stock Fall in the Biotechnology Field After It Has Gained 12.55% This Week?

A rating of 88 puts Aslan Pharmaceuticals Ltd (ASLN) near the top of the Biotechnology industry according to InvestorsObserver. Aslan Pharmaceuticals Ltd's score of 88 means it scores higher than 88% of stocks in the industry. Aslan Pharmaceuticals Ltd also received an overall rating of 59, putting it above 59% of all stocks. Biotechnology is ranked 91 out of the 148 industries.

ASLN has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on ASLN!

See Full ASLN Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Aslan Pharmaceuticals Ltd Stock Today?

Aslan Pharmaceuticals Ltd (ASLN) stock is trading at $3.05 as of 11:42 AM on Friday, Sep 3, a drop of -$0.05, or -1.77% from the previous closing price of $3.10. The stock has traded between $3.02 and $3.11 so far today. Volume today is below average. So far 225,237 shares have traded compared to average volume of 515,793 shares. Click Here to get the full Stock Report for Aslan Pharmaceuticals Ltd stock.